Literature DB >> 26858893

Synergistic Effects of Calcineurin Inhibitors and Steroids on Steroid Sensitivity of Peripheral Blood Mononuclear Cells.

Hironori Takeuchi1, Hitoshi Iwamoto2, Yuki Nakamura2, Toshihiko Hirano3, Osamu Konno2, Yu Kihara2, Naokazu Chiba2, Takayoshi Yokoyama2, Kiminori Takano2, Tatsunori Toraishi4, Kiyoshi Okuyama4, Chie Ikeda2, Sachiko Tanaka3, Kenji Onda3, Akiko Soga1, Yukiko Kikuchi1, Takashi Kawaguchi1, Shigeyuki Kawachi2, Sakae Unezaki1, Motohide Shimazu2.   

Abstract

The steroid receptor (SR) complex contains FKBP51 and FKBP52, which bind to tacrolimus (TAC) and cyclophilin 40, which, in turn, bind to cyclosporine (CYA); these influence the intranuclear mobility of steroid-SR complexes. Pharmacodynamic interactions are thought to exist between steroids and calcineurin inhibitors (CNIs) on the SR complex. We examined the effect of CNIs on steroid sensitivity. Methylprednisolone (MPSL) sensitivity was estimated as the concentration inhibiting mitosis in 50% (IC50) of peripheral blood mononuclear cells and as the area under the MPSL concentration-proliferation suppressive rate curves (CPS-AUC) in 30 healthy subjects. MPSL sensitivity was compared between the additive group (AG) as the MPSL sensitivity that was a result of addition of the proliferation suppressive rate of CNIs to that of MPSL and the mixed culture group (MCG) as MPSL sensitivity of mixed culture with both MPSL and CNIs in identical patients. IC50 values of MPSL and cortisol sensitivity were examined before and 2 months after CNI administration in 23 renal transplant recipients. IC50 and CPS-AUC values of MPSL were lower in the MCG than in the AG with administration of TAC and CYA. The CPS-AUC ratio of MCG and AG was lower in the TAC group. IC50 values of MPSL and cortisol tended to be lower after administration of TAC and CYA, and a significant difference was observed in the IC50 of cortisol after TAC administration. Steroid sensitivity increased with both TAC and CYA. Furthermore, TAC had a greater effect on increasing sensitivity. Thus, concomitant administration of CNIs and steroids can increase steroid sensitivity.

Entities:  

Keywords:  Calcineurin inhibitors (CNIs); Cyclosporine (CYA); Pharmacodynamic interaction; Steroid sensitivity; Tacrolimus (TAC)

Year:  2014        PMID: 26858893      PMCID: PMC4733836          DOI: 10.3727/215517914X681802

Source DB:  PubMed          Journal:  Cell Med        ISSN: 2155-1790


  17 in total

1.  Structure-function analysis of squirrel monkey FK506-binding protein 51, a potent inhibitor of glucocorticoid receptor activity.

Authors:  Wesley B Denny; Viravan Prapapanich; David F Smith; Jonathan G Scammell
Journal:  Endocrinology       Date:  2005-03-31       Impact factor: 4.736

2.  Glucocorticoid resistance in squirrel monkeys results from a combination of a transcriptionally incompetent glucocorticoid receptor and overexpression of the glucocorticoid receptor co-chaperone FKBP51.

Authors:  J M Westberry; P W Sadosky; T R Hubler; K L Gross; Jonathan G Scammell
Journal:  J Steroid Biochem Mol Biol       Date:  2006-05-24       Impact factor: 4.292

Review 3.  Cyclophilin 40: an Hsp90-cochaperone associated with apo-steroid receptors.

Authors:  Thomas Ratajczak; Bryan K Ward; Carmel Cluning; Rudi K Allan
Journal:  Int J Biochem Cell Biol       Date:  2009-03-24       Impact factor: 5.085

4.  Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder.

Authors:  Erick T Tatro; Ian P Everall; Marcus Kaul; Cristian L Achim
Journal:  Brain Res       Date:  2009-06-21       Impact factor: 3.252

5.  Biochemical and calmodulin binding properties of estrogen receptor binding cyclophilin expressed in Escherichia coli.

Authors:  T Ratajczak; A Carrello; R F Minchin
Journal:  Biochem Biophys Res Commun       Date:  1995-04-06       Impact factor: 3.575

6.  Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding.

Authors:  W B Denny; D L Valentine; P D Reynolds; D F Smith; J G Scammell
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

7.  Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates.

Authors:  J G Scammell; W B Denny; D L Valentine; D F Smith
Journal:  Gen Comp Endocrinol       Date:  2001-11       Impact factor: 2.822

8.  Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation. Marked difference between prednisolone and methylprednisolone.

Authors:  T Hirano; K Oka; H Takeuchi; E Sakurai; N Matsuno; T Tamaki; M Kozaki
Journal:  Transplantation       Date:  1994-05-15       Impact factor: 4.939

9.  Isolation and characterization of a 40-kDa cyclophilin-related protein.

Authors:  L J Kieffer; T Thalhammer; R E Handschumacher
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

10.  Control of glucocorticoid and progesterone receptor subcellular localization by the ligand-binding domain is mediated by distinct interactions with tetratricopeptide repeat proteins.

Authors:  Ananya Banerjee; Sumudra Periyasamy; Irene M Wolf; Terry D Hinds; Weidong Yong; Weinian Shou; Edwin R Sanchez
Journal:  Biochemistry       Date:  2008-09-05       Impact factor: 3.162

View more
  3 in total

1.  [Clinical effect of tacrolimus in the treatment of myasthenia gravis in children].

Authors:  Jiu-Wei Li; Fang Fang; Xiao-Tun Ren; Wei-Hua Zhang; Xin-Ying Yang; Chang-Hong Ren; Shuai Gong; Jun-Lan Lyu; Xiao-Hui Wang; Xu Wang; Hu-Sheng Wu; Chang-Hong Ding
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-09

2.  The Immunobiogram, a Novel In Vitro Assay to Evaluate Treatment Resistance in Patients Receiving Immunosuppressive Therapy.

Authors:  Jose Maria Portoles; Carlos Jimenez; Dario Janeiro; Maria O Lopez-Oliva; Alvaro Ortega-Carrion; Daniel Blanquez; Luis Arribas; Carlos Gomez; Teresa Diez; Julio Pascual; Isabel Portero
Journal:  Front Immunol       Date:  2021-01-25       Impact factor: 7.561

Review 3.  Therapeutic Potentials of Low-Dose Tacrolimus for Aberrant Endometrial Features in Polycystic Ovary Syndrome.

Authors:  Ahmad J H Albaghdadi; Frederick W K Kan
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.